STAT3 and intrahepatic cholangiocarcinoma: In intrahepatic cholangiocarcinoma STAT3 overexpression negatively correlates with the outcome of the patients [31], and in breast and lung cancer STAT3 has a key role in metastatic processes [32, 33].